HARP - Harpoon Therapeutics Inc - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-11.59M

Cash

61.39M

Avg Qtr Burn

-20.81M

Short % of Float

1.62%

Insider Ownership

1.04%

Institutional Own.

57.80%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
HPN328 (DLL3) Details Solid tumor/s, Cancer, Small cell lung cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HPN217 (BCMA) Details Multiple myeloma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HPN536 (MSLN) Details Ovarian cancer, Solid tumor/s, Pancreatic cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HPN424 (PSMA and CD3) Details Prostate cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.